About
About Poly Medicure Limited
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, including I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA balloon dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, including blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, and foley balloon and urine drainage catheters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.
Visit company website
5 years, 5 months ago
Poly Medicure Limited is currently in a long term uptrend where the price is trading 36.9% above its 200 day moving average.
From a valuation standpoint, the stock is 113.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.2.
Poly Medicure Limited's total revenue rose by 12.8% to $2B since the same quarter in the previous year.
Its net income has increased by 41.1% to $353M since the same quarter in the previous year.
Finally, its free cash flow grew by 39.0% to $849M since the same quarter in the previous year.
Based on the above factors, Poly Medicure Limited gets an overall score of 4/5.